A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
St. Jude Children's Research Hospital
Hackensack Meridian Health
Dartmouth-Hitchcock Medical Center
Astellas Pharma Inc
Masonic Cancer Center, University of Minnesota
Astellas Pharma Inc
H. Lee Moffitt Cancer Center and Research Institute
Astellas Pharma Inc
Therapeutic Advances in Childhood Leukemia Consortium
Sanofi
Center for International Blood and Marrow Transplant Research
Gilead Sciences
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Hoffmann-La Roche
Masonic Cancer Center, University of Minnesota
Stanford University
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Milton S. Hershey Medical Center
Northside Hospital, Inc.
Cornerstone Pharmaceuticals
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center